Member Info for Zoom0001

Maybe he could start with

We've secured an APAC production partner. Mentioned months ago.
We've secured a noteworthy contract - Based on the guidance that we will sell everything we make David Wilson last year.
We've completed the technical transfer with Abingdon - Expected Q1

I’ve always s accepted the facts good or bad, I just don’t have much time for the guesswork.

I’m still a loyal holder but getting increasingly ****ed of with the communication void as I’m sure most others are.

Hard to believe we’re in the middle of Wave 4 & Avacta have nothing to tell us. Just WTF is going on?

Maybe they submitted the correct paperwork.

Dr Smith may well blind us all with science but he’s also blinded many with his LFT pitches over the last year & a half.

I had shares (not many) when Avacta consolidated & added considerably more since initial news of the LFT.

Happy with progress in many respects but the guidance over the last 18 months has been beyond shambolic.

Nope. I think we’ll see a PM reversal.

We don’t know what the issue is Wyndrum. What we do know as Timster points out, that the test is currently being sold by one distributor & Avacta directly. We also know that Abingdon have an initial substantial order & are scaling up to produce between 1&2 million test per month. Further to this, Medusa have made very good progress towards HUA.

It’s all in the public domain.

That massive trade was my Richken style top up following Sujoods white hot tip this morning.

Not clear enough for you Wyndrum? No one’s arguing so your jobs done here.

Wyndrum - the answer is wait until the next update. If things are as poor as you repeatedly infer then the company can't hide away from the issue forever. Until then your speculation is as worthless as anyone else's

5 years.

Glad it’s sorted. Yes, I agree.

??

https://metro.co.uk/2021/12/05/bomb-squad-called-after-doctors-find-wwii-shell-stuck-up-mans-bum-15710207/amp/

The kids have a right to be impatient. They’re still waiting for last years presents.

A very recent Bioserv UK LinkedIn post Wyndrum. I very much doubt they would deem the partnership to be successful if they weren’t selling anything. I do agree that more insight will be required to budge the share price though.

BioServUK (a Calibre Scientific, Inc. company) continues its successful partnership with Avacta Life Science.

Just hope I’m able to do a Richken style top up before this weeks nailed on Sujood news drops.

AS has mentioned Covid LFT demand for 5 years in more than one presentation.

Almost like he can see the future.

https://www.bbc.com/news/health-59520945.amp

Please.

I reckon it’s going to be Ok. Based on nothing but I’m usually correct.

Some have been done for 30% today. You really need to know your onions to invest on this stinking market.